Readmission in the Case of Patients With Heart Failure

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02808221

Acronym

PRADO-IC

Enrollment

100

Registered

2016-06-21

Start date

2016-04-30

Completion date

2017-09-30

Last updated

2017-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart failure, heart disease, left ventricular

Brief summary

Heart failure (HF) is a serious chronic disease with frequent readmissions, some of which can be prevented by early action. The management of HF is complex: long, often difficult and costly. In France, nearly one million people suffer from HF and 120,000 new cases are diagnosed every year. With the aging population, this number will continue to evolve and become a real public health problem. Within 10 to 20 years ahead, WHO projects that heart failure in either the 3 most common diseases in industrialized countries. Investigators goals are to make an inventory of PRADO-IC project in terms of its effectiveness on readmission of patients with heart failure.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient aged 18 or over * Patient readmitted for heart failure

Exclusion criteria

* Population whose age is less than 18 years

Design outcomes

Primary

Measure	Time frame
The cost of re-hospitalization in the case of patients with heart failure reach	during 2015

Countries

France

Contacts

Primary ContactEmmanuel ANDRES, MD, PhD

Emmanuel.ANDRES@chru-strasbourg.fr333 8811 5066

Backup ContactMylène Radreau, MD

mylene.radreau@chru-strasbourg.fr333 8811 5066

Outcome results